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Available online 6 April 2016Ecbolin A and ecbolin B were isolated from ethyl acetate extract of Ecbolium viride (Forsk.)
Alston root and evaluated for larvicidal and growth disturbance activities against Aedes aegypti
L. (Diptera: Culicidae). For larvicidal activity, the third instar larvae of A. aegypti were exposed
to different concentrations viz., 1.0, 2.5, 5.0 and 10 ppm for each compound. Among the two
compounds screened, ecbolin B recorded highest larvicidal activity with LC50 and LC90 values
of 0.70 and 1.42 ppm, respectively. In control, the larval behaviour was normal. The active
compound ecbolin B was tested for growth disruption activity at sub lethal concentrations
viz., 0.5, 1.0 ppm and observed for malformation like larval gut elongation, larval longevity,
intermediates, malformed adults, failed adult emergence and compared with methoprene.
The results showed signiﬁcant level of larva–pupa intermediates, pupa–adult intermediates,
malformed adult emergence and less adult formation against A. aegypti. The histopathological
results revealed a severe damage on the midgut epithelial columnar cells (CC) and cuboidal
cells (CU) in ecbolin B treated larvae of A. aegypti. Similarly peritrophic membrane (pM) was
also observed to be damaged in the treated larvae. The present results suggest that, ecbolin
B could be used as a larvicidal agent against dengue vector A. aegypti.
© 2016 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists.
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Aedes aegypti1. Introduction
Mosquitoes are arthropod vectors responsible for transmitting various pathogens and mosquitoes are called as ‘Public Enemy
Number One’ (WHO, 1996a). Aedes aegypti L. is the primary vector, which is involved in the transmission of arboviruses respon-
sible for major diseases like dengue, dengue hemorrhagic fever, chikungunya and zika (Harrington et al., 2005; Kannathasan et al.,
2011). Dengue fever is endemic to many tropical countries including India (Ahmed and Akram, 2005; Valenca et al., 2013).
Mosquito borne diseases are major threat to human health. Currently, biological and chemical compounds like Bacillus
thuringiensis israelensis (Bti), Bacillus sphaericus (BS), pyrethroids, pyriproxyfen, permethrin, diﬂubenzuran and methoprene are
used as larvicidal and growth regulating products in integrated vector management (IVM) against A. aegypti (Bellini et al.,thu).
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79A.D. Reegan et al. / Parasite Epidemiology and Control 1 (2016) 78–842014). Botanical compounds are also a good choice for IVM based control of mosquito larvae (Sutthanont et al., 2010; Madhu
et al., 2010; Bayen, 2012; Muthu et al., 2012; Costa et al., 2012). Literature reveals many reports on phytocompounds against vec-
tor mosquitoes (Pelah et al., 2002; Jang et al., 2005; Chapagain et al., 2008; Perumalsamy et al., 2009; Han et al., 2013; da Silva
Gois et al., 2013). Many authors proved that, phytocompounds primarily affect the biosynthesis or the mechanisms of ecdysone,
showed disturbing effects on mosquito larval growth and moulting (Reegan et al., 2014; Sakthivadivel and Thilagavathy, 2003; da
Silva et al., 2013; Corzo et al., 2012).
Ecbolium viride (Forsk.) Alston (Acanthaceae) is a perennial woody under shrub (also known as Green Shrimp) found in the
plains of India and also in Arabia, Malaysia, Sri Lanka and Tropical Africa (Rastogi, 1979; Cecilia et al., 2014). This plant is widely
used in Indian traditional medicinal system such as Siddha, Ayurveda, Unani and Folk (Nair et al., 1985; Khare, 2007). In folk
medicine, aqueous extract of dried roots of the plant is used for menorrhagia (Datta and Maiti, 1968; Kirtikar and Basu, 1987).
The roots of E. viride used for the treatment of jaundice (Nair et al., 2007) and rheumatism (Shanmugam et al., 2009); while
the roots and leaves together are used against tumour (Yusuf et al., 2009). Further, the extracts obtained from the root of
E. viride showed a number of pharmacological activities viz., antioxidant (Babu et al., 2011), anti-inﬂammatory (Lalitha and
Sethuraman, 2010), anti-hepatotoxicity (Priyadharshni et al., 2011; Pandey, 2011), antiplasmodial, antitrypanosomal and antima-
larial activity (Abdel-Sattar et al., 2009).
In our earlier study, we have reported the larvicidal and pupicidal activities of ecbolin A and ecbolin B isolated from the ethyl
acetate extract of E. viride root against Culex quinquefasciatus (Cecilia et al., 2014). In the present study, the isolated compounds,
ecbolin A and ecbolin B were assessed for their effects on A. aegypti.
2. Materials and methods
2.1. Plant collection, extraction and isolation of ecbolin A and ecbolin B
Roots of E. viride (Fig. 1) were collected from Srirangam, Trichy, Tamil Nadu, India. The crude ethyl acetate extract (40 g) of
E. viride root was subjected to column chromatography over silica gel (200 g- Qualigens 100–200 mesh) and eluted with n-
hexane followed by combinations of n-hexane: ethyl acetate (95:5 to 0:100) and ethyl acetate: methanol (95:5 to 0:100). The
eluted fractions were combined based on the TLC results and ﬁnally a total of twelve fractions were obtained. Based on the
activity results, the fraction 6 and fraction 7 were selected for further crystallization and identiﬁed as ecbolin B and ecbolin A, re-
spectively. A detailed procedure on processing plant material, isolation of ecbolin A and ecbolin B (Figs. 2 and 3) and structural
elucidation have been described in our earlier reports (Cecilia et al., 2012a,b; 2014).
2.2. Insect rearing
Larvae of A. aegypti were obtained from the stock culture maintained at the Entomology Research Institute laboratory, which
were free of exposure to pathogens, insecticides or repellents. Rearing conditions were 27 ± 2 °C temperature, 75–85% relative
humidity and a photoperiod of 14 ± 0.5 h.Fig. 1. Ecbolium viride whole plant (a) and its root (b). Cecilia et al. (2014).
Fig. 2. Chemical structure of ecbolin A.
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Larval toxicity assay was performed as per the method prescribed by WHO (2005) with slight modiﬁcations. Test concentra-
tions were 1.0, 2.5, 5.0 and 10 ppm for each compound prepared using acetone (1 ml) and ﬁve replicates were maintained for
each concentration. Groups of twenty third instar larvae (In WHO larvicidal assay: 25 third instar larvae used) of A. aegypti
were used for each replication. The analytical standard of temephos (98% purity) were purchased from Sigma Aldrich and used
in the same concentrations with ﬁve replicates as positive control. Five controls were maintained, consisting of 1 ml acetone in
249 ml water. Same amount of acetone (1 ml), which was used to dissolve compound was added in control to ensure that the
larval mortality in treatments is due to the compounds. The dead larvae were registered after 24 h exposure period. The percent
mortality was calculated for each concentration using the formula (A.1) and corrections for mortality were done using formula
(A.2) of Abbott's (Abbott, 1987).
(A.1) Percentage of mortality:No:of Dead larvae
No:of Larvae introduced
 100(A.2) Corrected percentage of mortality:1−
n in T after treatment
n in C after treatment
 100Where n is the number of larvae, T is the treated and C is the control.Fig. 3. Chemical structure of ecbolin B.
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Based on the larvicidal activity results, the effective compound ecbolin B was used to study the growth disruption (morpho-
logical malformation) factors such as larvae–pupae intermediate, larval gut elongation, larval longevity, pupae–adult intermediate,
malformed adults and failed adult emergence at sub lethal concentrations viz., 0.5 and 1.0 ppm following the method of Reegan
et al. (2014). Five replicates of treated and control were maintained with twenty third instar larvae in each. Methoprene was used
as positive control. Abnormalities were observed 24 h post-exposure of the larvae till adult emergence. The larvae were fed with
yeast and dog biscuits (4:6 ratio).
2.5. Histopathological effects
The A. aegypti larvae, treated with ecbolin B at 10 ppm concentration were subjected to histopathological study. For this, the
treated and control larvae were ﬁxed in Carnoy 2 for 72 h as per the method of Raymond et al. (2007). The dehydration of tissue
was performed sequentially with alcohol viz., 50, 60, 70, 80, 90 and 100% for every 2 h. Then the samples were placed in xylene
for 6 h and transferred to warm oven with wax for embedding for about 2 h. The liquid wax was poured in paper boats with
sample, cooled and wax blocks were prepared. Then sectioning was made with the microtome (Minot microtom models
“Stiasnie”) at 8 μm.
Then the sections were placed on clean slides to adhere and left undisturbed for 24 h. Further, de-waxing was done with xy-
lene for 5 min and the hydration of sectioned tissue was performed sequentially with alcohol viz., 100, 90, 80, 70, 60, 50% and
then with distilled water. Then it was stained in Ehrlich's haematoxylin and again dehydration was made sequentially with alco-
hol viz., 50, 60, 70, 80, 90 and 100% and counterstained with eosin. A single wash was made in alcohol (100%) and two dips were
made in xylene and then mounted with one drop DPX. The observation was made with the microscope (Motic images plus 2.0
ML) connected to a computer and midgut cells of the treated and untreated larvae of A. aegypti were photographed. Observations
were made on epithelial columnar cells (CC), cuboidal cells (CU), peritrophic membrane (pM), nucleus (N), midgut content (MC)
and ectoperitrophic space (ES), muscles (M) of treated larvae for any damage caused by ecbolin B and compared with control.
2.6. Statistical analysis
The corrected percentage (using Abbott's formula) mortality values for each concentration of larvicidal data were subjected to
probit analysis (US EPA probit analysis software; version 1.5) to estimate lethal concentrations (LC50 and LC90 values) and the dif-
ferences were considered as signiﬁcant at P ≤ 0.05. The conﬁdence interval (95%) for LC50 and LC90 values was also produced from
the corrected percentage values by Abbott's formula. Kaplan–Meier comparison of survival with control was compared using SPSS
program (Version: 20.0) to support probit analysis. The calculated growth disruption rate were analysed in Graph Pad Prism ver-
sion 5.0 for Windows, Graph Pad Software, San Diego, CA, U.S.A.
3. Results
3.1. Larvicidal activity of ecbolin A and ecbolin B
The results of larvicidal activity of ecbolin A and B against A. aegypti larvae are given in Table 1. Concentration-dependent
mortality was observed. The highest concentrations (5 ppm and 10 ppm) of ecbolin B showed 100% larvicidal activity against
A. aegypti in 24 h. The LC50 and LC90 values of ecbolin B were 0.70, 1.42 ppm against the third instar larvae of A. aegypti, respec-
tively (Table 1).
A. aegypti larvae were less susceptible to ecbolin A in the present assessment and the LC50 and LC90 values of ecbolin A on
larval mortality were 8.56, 17.47 ppm against the third instar larvae of A. aegypti, respectively (Table 1). The LC50 and LC90 values
of temephos on mortality were 1.10, 2.31 ppm against the larvae of A. aegypti, respectively. Restless movement and convulsionTable 1
Lethal concentrations (in ppm) of ecbolin A and B against A. aegypti larvae compared with azadirachtin and temephos.
Mosquito
species
Treatment Mortality in
control
LC50 (ppm) 95% conﬁdence
limit
LC90 (ppm) 95% conﬁdence
limit
Slope ± SE Intercept ± SE χ2
(Total) LL UL LL UL
Aedes aegypti Ecbolin A⁎ 1 (100) 8.56 7.67 9.44 17.47 15.35 20.79 4.1 ± 0.4 1.1 ± 0.4 2.9#
Ecbolin B⁎⁎⁎ 0.70 0.63 0.77 1.42 1.28 1.62 4.2 ± 0.3 5.6 ± 0.1 4.8#
Temephos⁎⁎ 1.10 0.21 1.89 2.31 1.38 3.18 3.9 ± 0.4 5.1 ± 0.1 5.8#
LC50-lethal concentration that kills 50% of the exposed larvae; LC90-lethal concentration that kills 90% of the exposed larvae; LL-lower limit (95% conﬁdence limit);
UL-upper limit (95% conﬁdence limit). Control value was included in the Abbott's formula for correction. Kaplan Meier comparison of survival with control.
# p ≤ 0.05, level of signiﬁcance of chi-square values.
⁎ p ≤ 0.05.
⁎⁎ p ≤ 0.01.
⁎⁎⁎ p ≤ 0.001.
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2013), whereas in control (1 ml acetone in 249 ml water) the larval behaviour was normal. Chi-square values were signiﬁcant at
⁎p ≤ 0.05.
3.2. Growth disruption activity of ecbolin B
In the present study, larva–pupa intermediates, pupa–adult intermediates, incomplete/malformed adult emergence were
observed and less adult formation was observed with ecbolin B at sub lethal concentrations (Fig. 4). The positive control
methoprene also recorded malformation occurred mainly at the pupal stage and adult emergence was strongly inhibited at
1.0 ppm concentration (Fig. 4). But in control, the development was normal and 100% adult emergence was observed (Fig. 4).
Gut elongation and larval longevity were not observed during the present investigations. These observations suggest that the
ecbolin B contributing signiﬁcant level of growth disturbance and deformities at sub lethal concentrations against A. aegypti.
3.3. Histopathological effects of ecbolin B on larval midgut cells
The histopathological results revealed a severe damage on the midgut epithelial columnar cells (dCC) of treated larvae, which
was exposed to ecbolin B at 10 ppm concentration (Fig. 5B). Similarly peritrophic membrane (dpM) was also observed to be
ruptured in treated larvae of A. aegypti and the midgut content (MC) was oozed out into the ectoperitrophic space (ES); but in
control, peritrophic membrane (pM) was normal in appearance and midgut content (MC) was observed to be tightly packed
inside peritrophic membrane (Fig. 5A).
4. Discussion
Plant extracts and isolated compounds would be a valuable alternative to synthetic chemical insecticides and could be used in
integrated vector management programmes (Kabir et al., 2013).
Ecbolin is a lignan compound and in the present study ecbolin B was effective and showed strong larvicidal activity than
ecbolin A against A. aegypti (Table 1). Similarly, Park et al. (2005) identiﬁed two lignan constituents from Phryma leptostachya
Var. asiatica roots namely leptostachyol acetate and 8′-acetoxy-2,2′,6-trimethoxy-3,4,4′,5′-dimethylenedioxyphenyl-7,7′-
dioxabicyclo [3.3.0]octane. Their study revealed that leptostachyol acetate was effective and showed LC50 value of 0.41, 2.1, and
2.3 ppm against Culex pipiens pallens, A. aegypti, and O. togoi, respectively. In another study, three lignans namely, phrymarolin-
I, haedoxane A, and haedoxane E were isolated from the petroleum ether extract of Phyrma leptostachya L and tested for larvicidal
activity against C. pipiens pallens. The toxicity of each compound varied with LC50 value of 1.21, 0.025, and 0.15 ppm for
Phrymarolin-I, haedoxane A, and haedoxane E, respectively against the early fourth instar larvae of C. pipiens pallens (Xiao
et al., 2012). In another study, a lignan was identiﬁed as grandisin from Piper solmsianum, which showed 80% and 100% larval
mortality against A. aegypti at 10 mg/ml and 100 mg/ml, respectively (Cabral et al., 2009). In a study, Batallán et al. (2013) report-
ed the larvicidal activity of a lignan nordihydroguaiaretic acid against C. quinquefasciatus with LC50 value of 0.092 mg/ml. Kishore
et al. (2011) reviewed the efﬁcacy of plant derived lignans against mosquito larvae. Further, the larvicidal activity of ecbolin B
(LC50–0.70 ppm) was comparable to temephos, which showed LC50 value of 1.10 ppm during the present study (Table 1).Fig. 4. Proportion of larval deformity and mortality in A. aegypti upon exposure to ecbolin B (0.5 and 1.0 ppm) compared with methoprene (1.0 ppm) and control.
Fig. 5. Cross section parts of midgut of 3rd instar larvae of A. aegypti treated with ecbolin B (B) compared with control (A). Columnar cells (CC), damaged columnar
cells (dCC), cuboidal cells (CU), nucleus (N), peritrophic membrane (pM), damaged peritrophic membrane (dpM), midgut content (MC), ectoperitrophic space
(ES), muscle (M).
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recorded (Fig 4). Similar to our result, Nathan et al. (2008) has demonstrated the growth and moulting disrupting effects of two
triterpenoids viz., 3β,24,25-trihydroxycycloartane and beddomeilactone isolated from the leaves of Dysoxylum malabaricum and
Dysoxylum beddomei against Anopheles stephensi at 1.0 and 2.5 ppm concentrations. In another study, incomplete adult emergence
was reported with Copaifera sp. oil at 48 mg/l concentration against A. aegypti (Prophiro et al., 2012). Similarly, Nayar et al. (2002)
evaluated the growth regulatory activity of s-methoprene and the results varied among different mosquito species. In their study,
the maximum emerging inhibition of 84% and 44.3% recorded at 0.4 and 0.05 ppm with C. quinquefasciatus and Aedes albopictus,
respectively. da Silva and Mendes (2007) reported abnormalities like dead pupae, larva-like abdomen, pupal–adult intermediate
with methoprene at 70 ppb concentration against A. aegypti.
5. Conclusion
In summary, the isolated compound ecbolin B from ethyl acetate extract of E. viride root showed the highest larval mortality at
the lowest concentration than ecbolin A against A. aegypti larvae. Ecbolin B also exhibited intermediates and malformed adults at
sub lethal concentrations. The histopathological results revealed a severe damage on the midgut epithelial columnar cells (CC) and
cuboidal cells (CU) of ecbolin B treated larvae. The compound ecbolin B could be used as an effective larvicidal agent for the
control of A. aegypti mosquitoes. The ﬁeld application of Ecbolin B through integrated vector management programme would
be target speciﬁc and environmental friendly.
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